fda pulls semaglutide is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Weight loss patients fret over

By mimicking a natural hormone, it helps you feel fuller longer, reduces cravings, and puts you back in control of your eating habits

Female patients demonstrated a lower likelihood of developing OSA than males, consistent with existing literature on gender differences in OSA prevalence

Developed by Eli Lilly, it is available under the brand names Mounjaro and Zepbound

Data on whether tumor size [169172] or anatomic location [173, 174] affect response are inconclusive

Placebo participants lost 3.1%

We thank Eduard Kober, Hlne Savoye (both employed by Sanofi), and Mlanie Bovo (employed by Business France) for their support during the conduct and analysis of this study